Drugs
northbook: The Global Therapeutic Drug Monitoring Market is projected to reach USD 1.63 billion in 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% ...
Northbrook:
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechno ...
Vienna: Vienna, Tuesday, April 23, 2019. Marinomed Biotech AG, a globally active biopharmaceutical company with headquarters in Vienna, has announced the successful completion of the pivotal Phase III study f ...
Lincoln: BOSTON, October 31, 2018 - PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that the Company has launched a new China Advisory Service to he ...
Wien: • Finance expert Pascal Schmidt joins the management team as of August 1, 2018
• Growth trajectory maintained with 84% increase in revenues in 2017
• Significant progression in the development ...
Wien: Karl Landsteiner Private University in Krems opens new biomechanics laboratory
Krems, 21 March 2018 − A brand new biomechanics laboratory equipped with latest technology is coming on str ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 11/20/17 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its pre ...
SASKATOON, SASKATCHEWAN and OAKVILLE, ONTARIO: SASKATOON, SASKATCHEWAN and OAKVILLE, ONTARIO -- (Marketwired) -- 11/17/17 -- Editors Note: A photo for this release is available on the Canadian Press picture wire via Marketwired.Transaction Highli ...
MIAMI, FL: Highlights recent accomplishments and upcoming milestones ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 11/14/17 -- (NASDAQ: CBLI) today reported financial results and development progress for the third quarter ended September 30, 2017.Cleveland BioLabs reported a net l ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 11/13/17 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its pr ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 11/09/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today reported financial results for i ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 11/07/17 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its pr ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 11/02/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, will release its third quarter 2017 fi ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 10/10/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Jeffrey Kadanoff, ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 10/10/17 -- Pursuant to the early warning requirements of National Instrument 62-103, Knight Therapeutics Inc. (TSX: GUD) ("Knight") announced today an ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 10/04/17 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ: ACST)(TSX VENTURE: ACST) announces that in accordance with the terms of ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 09/21/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Samira Sakhia, Pr ...
OXFORD, UNITED KINGDOM: OXFORD, UNITED KINGDOM -- (Marketwired) -- 09/07/17 -- Circassia Pharmaceuticals Plc (LSE: CIR)(LSE: CIR)Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 08/31/17 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ: ACST)(TSX VENTURE: ACST), today announced the grant of an aggregate of 1 ...
